211 related articles for article (PubMed ID: 31794434)
1. Chikungunya virus replication in skeletal muscle cells is required for disease development.
Lentscher AJ; McCarthy MK; May NA; Davenport BJ; Montgomery SA; Raghunathan K; McAllister N; Silva LA; Morrison TE; Dermody TS
J Clin Invest; 2020 Mar; 130(3):1466-1478. PubMed ID: 31794434
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
Issac TH; Tan EL; Chu JJ
J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
[TBL] [Abstract][Full Text] [Related]
3. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
[TBL] [Abstract][Full Text] [Related]
5. Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA.
Young AR; Locke MC; Cook LE; Hiller BE; Zhang R; Hedberg ML; Monte KJ; Veis DJ; Diamond MS; Lenschow DJ
PLoS Pathog; 2019 Aug; 15(8):e1007993. PubMed ID: 31465513
[TBL] [Abstract][Full Text] [Related]
6. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.
Silva LA; Dermody TS
J Clin Invest; 2017 Mar; 127(3):737-749. PubMed ID: 28248203
[TBL] [Abstract][Full Text] [Related]
7. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication.
Scholte FE; Tas A; Albulescu IC; Žusinaite E; Merits A; Snijder EJ; van Hemert MJ
J Virol; 2015 Apr; 89(8):4457-69. PubMed ID: 25653451
[TBL] [Abstract][Full Text] [Related]
8. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
9. Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.
Rausalu K; Utt A; Quirin T; Varghese FS; Žusinaite E; Das PK; Ahola T; Merits A
Sci Rep; 2016 Nov; 6():37124. PubMed ID: 27845418
[TBL] [Abstract][Full Text] [Related]
10. Mosquito saliva induced cutaneous events augment Chikungunya virus replication and disease progression.
Agarwal A; Joshi G; Nagar DP; Sharma AK; Sukumaran D; Pant SC; Parida MM; Dash PK
Infect Genet Evol; 2016 Jun; 40():126-135. PubMed ID: 26925703
[TBL] [Abstract][Full Text] [Related]
11. Chikungunya infection: de-linking replication from symptomatology reveals the central role of muscle.
Moscona A
J Clin Invest; 2020 Mar; 130(3):1099-1101. PubMed ID: 32039916
[TBL] [Abstract][Full Text] [Related]
12. Chikungunya Virus Vaccine Candidate Incorporating Synergistic Mutations Is Attenuated and Protects Against Virulent Virus Challenge.
Lentscher AJ; McAllister N; Griswold KA; Martin JL; Welsh OL; Sutherland DM; Silva LA; Dermody TS
J Infect Dis; 2023 Feb; 227(3):457-465. PubMed ID: 35196388
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a Novel Primary Human Skeletal Myoblast Cellular Model for Chikungunya Virus Infection and Pathogenesis.
Hussain KM; Lee RC; Ng MM; Chu JJ
Sci Rep; 2016 Feb; 6():21406. PubMed ID: 26892458
[TBL] [Abstract][Full Text] [Related]
14. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus.
Rohatgi A; Corbo JC; Monte K; Higgs S; Vanlandingham DL; Kardon G; Lenschow DJ
J Virol; 2014 Mar; 88(5):2414-25. PubMed ID: 24335291
[TBL] [Abstract][Full Text] [Related]
15. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
Acharya D; Paul AM; Anderson JF; Huang F; Bai F
PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
[TBL] [Abstract][Full Text] [Related]
16. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.
Morrison TE; Oko L; Montgomery SA; Whitmore AC; Lotstein AR; Gunn BM; Elmore SA; Heise MT
Am J Pathol; 2011 Jan; 178(1):32-40. PubMed ID: 21224040
[TBL] [Abstract][Full Text] [Related]
18. Aedes Aegypti saliva enhances chikungunya virus replication in human skin fibroblasts via inhibition of the type I interferon signaling pathway.
Wichit S; Diop F; Hamel R; Talignani L; Ferraris P; Cornelie S; Liegeois F; Thomas F; Yssel H; Missé D
Infect Genet Evol; 2017 Nov; 55():68-70. PubMed ID: 28866137
[TBL] [Abstract][Full Text] [Related]
19. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
[TBL] [Abstract][Full Text] [Related]
20. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Her Z; Teng TS; Tan JJ; Teo TH; Kam YW; Lum FM; Lee WW; Gabriel C; Melchiotti R; Andiappan AK; Lulla V; Lulla A; Win MK; Chow A; Biswas SK; Leo YS; Lecuit M; Merits A; Rénia L; Ng LF
EMBO Mol Med; 2015 Jan; 7(1):24-41. PubMed ID: 25452586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
